Category: Health
A new blood test, APS2, shows 91% accuracy in diagnosing Alzheimer's disease in early-stage patients, outperforming primary care doctors' 61% accuracy. Developed by Dr. Sebastian Palmquist's team, the test measures levels of tau and amyloid proteins, crucial for early diagnosis. While promising, the test is not yet approved for routine use and raises questions about cost and FDA approval.
Keywords: Alzheimer's disease, blood test, diagnosis
Update At: 7/29/2024